Osuna, Alina; Garrido, Jesus
April 2008
Acta Reumatológica Portuguesa;2008, Vol. 33 Issue 2, p224
Academic Journal
Cyclophosphamide (CYC) is a classical drug for the treatment of severe Wegener's granulomatosis (WG). However, as it causes substantial toxicity, alternative agents should be considered if optimal therapeutic CYC dose is not tolerated by an individual patient. We report the successful use of mycophenolate mofetil (MMF) in a 35-year-old patient with renal biopsy-proven pANCA WG and lung involvement. Despite a good clinical and biological response to the standard induction of remission therapy, the patient developed persistent severe CYC-related leucopoenia after two months of treatment. Thus, CYC was replaced by MMF, and during the three and a half years of follow-up the patient never required haemodialysis. He has remained in complete clinical remission for the last two years, without MMF-related adverse effects.


Related Articles

  • Kresentik glomerülonefritle baÅŸvuran bir Wegener granülomatozu olgusu. Tülpar, Sebahat; Baştuğ, Funda; Poyrazoğlu, M.Hakan; Gündüz, Zübeyde; Akgün, Hülya; Yıkılmaz, Ali // Dicle Medical Journal / Dicle Tip Dergisi;2010, Vol. 37 Issue 4, p413 

    Wegener granulomatosis is a rare vasculitis in childhood and is associated with morbidity and mortality in untreated cases. We reported a 10 year-old female who presented with pulmonary renal syndrome. Laboratory investigations revealed the diagnosis of Wegener granulomatosis, and...

  • Cerebral Wegener's Granuloma: Surgery Mandatory for Diagnosis and Treatment. Nicolosi, Federico; Nodari, Giovanni; Spena, Giannantonio; Roca, Elena; Migliorati, Karol; Esposito, Giacomo; Stefini, Roberto; Fontanella, Marco; Panciani, Pier Paolo // Case Reports in Neurological Medicine;2013, p1 

    The involvement of the central nervous system in case of Wegener granulomatosis (WG) is infrequent and usually leads to cranial nerve abnormalities, cerebrovascular events, and seizures. Meningeal involvement is quite rare and usually is due to the spreading from adjacent disease in the skull...

  • Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis. Wilde, Benjamin; Van Paassen, Pieter; Damoiseaux, Jan; Heerings-Rewinkel, Petra; Van Rie, Henk; Witzke, Oliver; Tervaert, Jan Willem Cohen // Nephrology Dialysis Transplantation;Jul2009, Vol. 24 Issue 7, p2151 

    Background. Dendritic cells (DCs) maintain immune tolerance and are able to initiate immune responses. Their involvement in ANCA-associated vasculitis (AAV) is unknown. In this study, the participation of DC subsets is investigated in renal biopsies of AAV patients.

  • Mononeuritis multiplex as a presenting feature of Wegener granulomatosis: a case report. Peshin, R.; O’Gradaigh, D. // Clinical Rheumatology;Aug2007, Vol. 26 Issue 8, p1389 

    We report the case of a man presenting with clinical features of a mononeuritis multiplex, a perinuclear-ANCA (p-ANCA), and a renal biopsy suggestive of Wegener granulomatosis (WG). We wish to highlight this case as a learning point for clinicians as WG rarely presents in this form, and can be...

  • Splenectomy and unilateral nephrectomy complicating granulomatosis with polyangitis. George, S. A.; Francis, I. // Indian Journal of Nephrology;Mar/Apr2014, Vol. 24 Issue 2, p134 

    The article presents a case study of a 20-year-old woman suffering from hypertension, chronic sinusitis and high level of serum creatinine. The patient was diagnosed with granulomatosis with polyangitis (GPA) and treated through plasma exchange, mycophenolate mofetil and oral prednisolone....

  • Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. Solans-Laqué, R.; Bosch-Gil, J. A.; Canela, M.; Lorente, J.; PaIlisa, E.; Vilardell-Tarrés, M. // Lupus;Sep2008, Vol. 17 Issue 9, p832 

    The objective of the study was to evaluate the clinical features, response to treatment, and long- term outcome of subglottic stenosis (SGS) in a series of patients diagnosed as having Wegener's granulomatosis (WG) at a single institution. Subglottic stenosis developed in 6 out of 51 (11.7%)...

  • Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up. Henes, J. C.; Kanz, L.; Koetter, I. // Rheumatology International;Mar2011, Vol. 31 Issue 3, p425 

    The article discusses the long-time observation on patients with Wegener's granulomatosis (WG) with rituximab (RTX) as induction treatment and leflunomide (LEF) for maintenance. It examines 10 RTX-treated patients with associated vasculitis and a follow-up period of 33.5 months without...

  • Lacrimal drainage surgery in patients with rare nasal diseases. Jain, R.; Rose, G. E. // Eye;Nov2007, Vol. 21 Issue 11, p1361 

    AimTo examine the results of open lacrimal drainage surgery in patients with rare nasal diseases.MethodA retrospective review of a group of patients with rare nasal disease who underwent open lacrimal surgery over a 15-year period at Moorfields Eye Hospital. Three main groups of disease were...

  • Respuesta a rituximab en un paciente con granulomatosis de Wegener refractaria a terapia convencional. Fernández, Inmaculada Macías // Reumatologia Clinica;ene/feb2010, Vol. 6 Issue 1, p56 

    Male with diagnosis of Wegener's granulomatosis associated to anti-proteinase 3 antibodies that improved initially to the treatment with high dose glucocorticoids and ciclophosphamide, but in a relapse he did not have good response to glucocorticoid treatment, ciclophosphamide, methotrexate nor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics